124 related articles for article (PubMed ID: 11699840)
1. Differences in the method by which plasma is separated from whole blood influences amphotericin B plasma recovery and distribution following amphotericin B lipid complex incubation within whole blood.
Ramaswamy M; Wasan KM
Drug Dev Ind Pharm; 2001 Sep; 27(8):871-5. PubMed ID: 11699840
[TBL] [Abstract][Full Text] [Related]
2. Preferential distribution of amphotericin B lipid complex into human HDL3 is a consequence of high density lipoprotein coat lipid content.
Kennedy AL; Wasan KM
J Pharm Sci; 1999 Nov; 88(11):1149-55. PubMed ID: 10564063
[TBL] [Abstract][Full Text] [Related]
3. Role of phospholipid transfer protein on the plasma distribution of amphotericin B following the incubation of different amphotericin B formulations.
Patankar N; Wasan KM
Pharm Res; 2006 May; 23(5):1020-4. PubMed ID: 16715392
[TBL] [Abstract][Full Text] [Related]
4. Amphotericin B lipid complex or amphotericin B multiple-dose administration to rabbits with elevated plasma cholesterol levels: pharmacokinetics in plasma and blood, plasma lipoprotein levels, distribution in tissues, and renal toxicities.
Ramaswamy M; Peteherych KD; Kennedy AL; Wasan KM
Antimicrob Agents Chemother; 2001 Apr; 45(4):1184-91. PubMed ID: 11257033
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics, distribution in serum lipoproteins and tissues, and renal toxicities of amphotericin B and amphotericin B lipid complex in a hypercholesterolemic rabbit model: single-dose studies.
Wasan KM; Kennedy AL; Cassidy SM; Ramaswamy M; Holtorf L; Chou JW; Pritchard PH
Antimicrob Agents Chemother; 1998 Dec; 42(12):3146-52. PubMed ID: 9835506
[TBL] [Abstract][Full Text] [Related]
6. Behavior of amphotericin B lipid complex in plasma in vitro and in the circulation of rats.
Bhamra R; Sa'ad A; Bolcsak LE; Janoff AS; Swenson CE
Antimicrob Agents Chemother; 1997 May; 41(5):886-92. PubMed ID: 9145839
[TBL] [Abstract][Full Text] [Related]
7. Heat treatment of amphotericin b modifies its serum pharmacokinetics, tissue distribution, and renal toxicity following administration of a single intravenous dose to rabbits.
Kwong EH; Ramaswamy M; Bauer EA; Hartsel SC; Wasan KM
Antimicrob Agents Chemother; 2001 Jul; 45(7):2060-3. PubMed ID: 11408223
[TBL] [Abstract][Full Text] [Related]
8. Development and characterization of oral lipid-based amphotericin B formulations with enhanced drug solubility, stability and antifungal activity in rats infected with Aspergillus fumigatus or Candida albicans.
Wasan EK; Bartlett K; Gershkovich P; Sivak O; Banno B; Wong Z; Gagnon J; Gates B; Leon CG; Wasan KM
Int J Pharm; 2009 May; 372(1-2):76-84. PubMed ID: 19236839
[TBL] [Abstract][Full Text] [Related]
9. Assessing the antifungal activity and toxicity profile of amphotericin B lipid complex (ABLC; Abelcet) in combination with caspofungin in experimental systemic aspergillosis.
Sivak O; Bartlett K; Risovic V; Choo E; Marra F; Batty DS; Wasan KM
J Pharm Sci; 2004 Jun; 93(6):1382-9. PubMed ID: 15124198
[TBL] [Abstract][Full Text] [Related]
10. Dose-dependent pharmacokinetics of amphotericin B lipid complex in rabbits.
Walsh TJ; Jackson AJ; Lee JW; Amantea M; Sein T; Bacher J; Zech L
Antimicrob Agents Chemother; 2000 Aug; 44(8):2068-76. PubMed ID: 10898677
[TBL] [Abstract][Full Text] [Related]
11. Assessing the antifungal activity, pharmacokinetics, and tissue distribution of amphotericin B following the administration of Abelcet and AmBisome in combination with caspofungin to rats infected with Aspergillus fumigatus.
Wasan KM; Sivak O; Rosland M; Risovic V; Bartlett K
J Pharm Sci; 2007 Jul; 96(7):1737-47. PubMed ID: 17080414
[TBL] [Abstract][Full Text] [Related]
12. Ocular distribution of intravenously administered lipid formulations of amphotericin B in a rabbit model.
Goldblum D; Rohrer K; Frueh BE; Theurillat R; Thormann W; Zimmerli S
Antimicrob Agents Chemother; 2002 Dec; 46(12):3719-23. PubMed ID: 12435667
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary extraction and accumulation of lipid formulations of amphotericin B.
Matot I; Pizov R
Crit Care Med; 2000 Jul; 28(7):2528-32. PubMed ID: 10921589
[TBL] [Abstract][Full Text] [Related]
14. Compartmentalized intrapulmonary pharmacokinetics of amphotericin B and its lipid formulations.
Groll AH; Lyman CA; Petraitis V; Petraitiene R; Armstrong D; Mickiene D; Alfaro RM; Schaufele RL; Sein T; Bacher J; Walsh TJ
Antimicrob Agents Chemother; 2006 Oct; 50(10):3418-23. PubMed ID: 17005824
[TBL] [Abstract][Full Text] [Related]
15. A comparative study of plasma concentrations of liposomal amphotericin B (L-AMP-LRC-1) in adults, children and neonates.
Kotwani RN; Gokhale PC; Bodhe PV; Kirodian BG; Kshirsagar NA; Pandya SK
Int J Pharm; 2002 May; 238(1-2):11-5. PubMed ID: 11996806
[TBL] [Abstract][Full Text] [Related]
16. Analytical method development and comparability study for AmBisome® and generic Amphotericin B liposomal products.
Liu Y; Mei Z; Mei L; Tang J; Yuan W; Srinivasan S; Ackermann R; Schwendeman AS
Eur J Pharm Biopharm; 2020 Dec; 157():241-249. PubMed ID: 32980448
[TBL] [Abstract][Full Text] [Related]
17. Potential mechanisms by which Peceol increases the gastrointestinal absorption of amphotericin B.
Risovic V; Sachs-Barrable K; Boyd M; Wasan KM
Drug Dev Ind Pharm; 2004 Aug; 30(7):767-74. PubMed ID: 15491054
[TBL] [Abstract][Full Text] [Related]
18. Assessing the Safety, Tolerability, Pharmacokinetics, and Biodistribution of Novel Oral Formulations of Amphotericin B following Single- and Multiple-Dose Administration to Beagle Dogs.
Wasan KM; Wasan EK; Hnik P
Antimicrob Agents Chemother; 2020 Oct; 64(11):. PubMed ID: 32816728
[TBL] [Abstract][Full Text] [Related]
19. Unidirectional inhibition of lipid transfer protein I-mediated transfer of cholesteryl esters between high-density and low-density lipoproteins by amphotericin B lipid complex.
Sivak O; Lau B; Patankar N; Wasan KM
Pharm Res; 2004 Dec; 21(12):2336-9. PubMed ID: 15648266
[TBL] [Abstract][Full Text] [Related]
20. Plasma Bead Entrapped Liposomes as a Potential Drug Delivery System to Combat Fungal Infections.
Fatima MT; Islam Z; Ahmad E; Hoque M; Yamin M
Molecules; 2022 Feb; 27(3):. PubMed ID: 35164370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]